2026-01-14 01:39:58

Injective's validator lineup is expanding—this time, it's all heavyweight players. Fortune 500 companies and mainstream crypto infrastructure providers are joining one after another, demonstrating that this chain has indeed gained industry trust. And don't forget, the staking return for participating validators exceeds 12% in $INJ, making it a tangible and real opportunity for institutions. With both ecosystem development and economic incentives in place, Injective is attracting more mainstream participants with concrete data.

INJ-3,71%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

16 Likes

Reward
16
7
Repost
Share

Comment

0/400

TopBuyerBottomSeller

· 01-15 11:59

A 12% staking return is indeed attractive, just worried about dilution later on.

View OriginalReply0

UnluckyValidator

· 01-15 08:55

12% return? Come on, it's good if you actually get half of that.

View OriginalReply0

BlockchainTalker

· 01-14 02:09

Actually, let's break this down—12% APY sounds nice on paper, but have we considered the validator set concentration risk here? 🤔 massive institutions dumping capital creates its own set of problems...

Reply0

FlashLoanLord

· 01-14 02:05

This lineup really can perform, and a 12% return rate is truly attractive to institutions.

View OriginalReply0

HodlKumamon

· 01-14 02:04

12% staking yield? After calculating, it indeed sounds more attractive than many traditional financial products, and the logic for institutional players to enter is valid.

View OriginalReply0

WagmiWarrior